DEFEROXAMINE MESYLATE J Code: J0895

Drug & Product Overview

HCPCS Descriptor Injection, deferoxamine mesylate, 500 mg

HCPCS Added Date January 1, 1992

Manufacturer Multiple Manufacturers

Route of Administration Intramuscular, Intravenous, Subcutaneous

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Solution | Not Available

About DEFEROXAMINE MESYLATE

Deferoxamine Mesylate is a medication aligned to the HCPCS J Code: J0895 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intramuscular, intravenous, or subcutaneous routes and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used along with other treatments (such as causing vomiting with syrup of ipecac, stomach pumping) to treat sudden iron poisoning. It is most effective when given as soon as possible after the iron was eaten. This medication can also be used to help get rid of iron in patients with high iron levels due to many blood transfusions. Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping the kidneys and gallbladder get rid of the extra iron. This medication is not recommended for use in children less than 3 years old (see also Precautions section).

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 12 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00078-0467-91	Desferal	Novartis Pharmaceuticals Corporation	4	500 MG
00409-2337-25	Deferoxamine Mesylate	Hospira, Inc.	16	Deferoxamine Mesylate Intramuscular In… Login for More
60505-6236-06	Deferoxamine mesylate	Apotex Corp.	4	500 MG
60505-6238-06	Deferoxamine Mesylate	Apotex Corp	4	500 MG
63323-0597-10	Deferoxamine	Fresenius Kabi USA, LLC	1	503.5 MG / 5.3 ML
•••••-••••-•• Log in to view	DEFEROXAMINE MESYLATE
	DEFEROXAMINE MESYLATE
	DEFEROXAMINE MESYLATE

Login to view 7 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

DEFEROXAMINE MESYLATE Pricing & Reimbursement

J0895 Private Payer Reimbursement

$8.53 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

DEFEROXAMINE MESYLATE CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
96372 Login for More	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular Login for More
96374 Login for More	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug), IV push, single, or initial substance/drug Login for More

JW / JZ modifiers apply

CMS has identified Deferoxamine Mesylate (J0895) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

DEFEROXAMINE MESYLATE Medically Unlikely Edits (MUE)

The most billing units of J0895 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 mg.

Practitioner Office & Hospital Outpatient

12 units / day

= 6,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

DEFEROXAMINE MESYLATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Iron Intoxication Chronic Iron Overload

Drug Class

Iron Chelating Activity [MoA]Iron Chelator [EPC]

Frequently Asked Questions

Is there an available Deferoxamine Mesylate billing and coding guide?

We have not yet identified a manufacturer source of Deferoxamine Mesylate billing and coding information.

Are there any available Deferoxamine Mesylate patient assistance programs?

Our team did not identify a source for Deferoxamine Mesylate patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Deferoxamine Mesylate prescribing information?

DEFEROXAMINE MESYLATE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Deferoxamine Mesylate side effect information?

Our team has not yet identified a source of side effects information for DEFEROXAMINE MESYLATE. Please check back in a few weeks.

Does billing DEFEROXAMINE MESYLATE require JZ/JW wastage modifiers?

CMS has identified DEFEROXAMINE MESYLATE(J0895) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.